These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16946193)

  • 1. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.
    Riccardi P; Zald D; Li R; Park S; Ansari MS; Dawant B; Anderson S; Woodward N; Schmidt D; Baldwin R; Kessler R
    Am J Psychiatry; 2006 Sep; 163(9):1639-41. PubMed ID: 16946193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
    Riccardi P; Li R; Ansari MS; Zald D; Park S; Dawant B; Anderson S; Doop M; Woodward N; Schoenberg E; Schmidt D; Baldwin R; Kessler R
    Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [¹⁸F]fallypride.
    Riccardi P; Park S; Anderson S; Doop M; Ansari MS; Schmidt D; Baldwin R
    Synapse; 2011 Feb; 65(2):99-102. PubMed ID: 20506565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
    Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
    Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M; Kegeles LS; Xu X; Thompson JL; Urban N; Castrillon J; Hackett E; Bae SA; Laruelle M; Abi-Dargham A
    Synapse; 2010 May; 64(5):350-62. PubMed ID: 20029833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions.
    Woodward ND; Cowan RL; Park S; Ansari MS; Baldwin RM; Li R; Doop M; Kessler RM; Zald DH
    Am J Psychiatry; 2011 Apr; 168(4):418-26. PubMed ID: 21159728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy.
    Yakushev IY; Dupont E; Buchholz HG; Tillmanns J; Debus F; Cumming P; Heimann A; Fellgiebel A; Luhmann HJ; Landvogt C; Werhahn KJ; Schreckenberger M; Potschka H; Bartenstein P
    Epilepsia; 2010 Mar; 51(3):415-22. PubMed ID: 19694792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
    Riccardi P; Baldwin R; Salomon R; Anderson S; Ansari MS; Li R; Dawant B; Bauernfeind A; Schmidt D; Kessler R
    Biol Psychiatry; 2008 Jan; 63(2):241-4. PubMed ID: 17586476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J; Christian BT; Narayanan TK; Shi B; Collins D
    Brain Res; 2005 Jan; 1032(1-2):77-84. PubMed ID: 15680944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
    Anand A; Verhoeff P; Seneca N; Zoghbi SS; Seibyl JP; Charney DS; Innis RB
    Am J Psychiatry; 2000 Jul; 157(7):1108-14. PubMed ID: 10873919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
    Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
    Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized in vivo detection of dopamine release using 18F-fallypride PET.
    Ceccarini J; Vrieze E; Koole M; Muylle T; Bormans G; Claes S; Van Laere K
    J Nucl Med; 2012 Oct; 53(10):1565-72. PubMed ID: 22933820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.
    Slifstein M; Narendran R; Hwang DR; Sudo Y; Talbot PS; Huang Y; Laruelle M
    Synapse; 2004 Oct; 54(1):46-63. PubMed ID: 15300884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
    Aalto S; Hirvonen J; Kaasinen V; Hagelberg N; Kajander J; Någren K; Seppälä T; Rinne JO; Scheinin H; Hietala J
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):475-83. PubMed ID: 18985345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [
    Smith CT; Dang LC; Burgess LL; Perkins SF; San Juan MD; Smith DK; Cowan RL; Le NT; Kessler RM; Samanez-Larkin GR; Zald DH
    Psychopharmacology (Berl); 2019 Feb; 236(2):581-590. PubMed ID: 30350220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.